| Literature DB >> 31484413 |
Adrián Cortés-Martín1, María Romo-Vaquero1, Izaskun García-Mantrana2, Ana Rodríguez-Varela3, María Carmen Collado2, Juan Carlos Espín1, María Victoria Selma4.
Abstract
The metabolism of dietary polyphenols ellagitannins by the gut-microbiota allows the human stratification in urolithin metabotypes depending on the final urolithins produced. Metabotype-A only produces urolithin-A, metabotype-B yields urolithin-B and isourolithin-A in addition to urolithin-A, and metabotype 0 does not produce urolithins. Metabotype-A has been suggested to be 'protective', and metabotype-B dysbiotic-prone to cardiometabolic impairments. We analyzed the gut-microbiome of 40 healthy women and determined their metabotypes and enterotypes, and their associations with anthropometric and gut-microbial changes after 3 weeks, 4, 6, and 12 months postpartum. Metabotype-A was predominant in mothers who lost weight (≥2 kg) (75%) versus metabotype-B (54%). After delivery, the microbiota of metabotype-A mothers changed, unlike metabotype-B, which barely changed over 1 year. The metabotype-A discriminating bacteria correlated to the decrease of the women's waist while some metabotype-B bacteria were inversely associated with a reduction of body mass index (BMI), waist, and waist-to-hip ratio. Metabotype-B was associated with a more robust and less modulating microbial and anthropometric profiles versus metabotype-A, in which these profiles were normalized through the 1-year follow-up postpartum. Consequently, urolithin metabotypes assessment could be a tool to anticipate the predisposition of women to normalize their anthropometric values and gut-microbiota, significantly altered during pregnancy and after childbirth.Entities:
Keywords: body mass index; ellagitannins; gut dysbiosis; gut microbiome; lactation; polyphenols; postpartum
Mesh:
Substances:
Year: 2019 PMID: 31484413 PMCID: PMC6769946 DOI: 10.3390/nu11092079
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Study design of mothers through postpartum.
Evolution of urolithin metabotypes (UMs) and enterotypes distribution in women (n = 32) for one year after delivery.
| Volunteers (%) | Postpartum Periods | |||
|---|---|---|---|---|
| T1 * | T2 | T3 | T4 | |
| Enterotype 1 | 9 | 9 | 9 | 14 |
| Enterotype 2 | 3 | 0 | 0 | 0 |
| Enterotype 3 | 88 | 91 | 91 | 86 |
| UM-0 | 0 | 0 | 0 | 0 |
| UM-A ( | 50 | 50 | 53 | 60 |
| UM-B | 50 | 50 | 47 | 40 |
| Normoweight | 50.0 | 59.4 | 59.4 | 62.5 |
| Overweight | 37.5 | 31.3 | 31.3 | 25.0 |
| Obese | 12.5 | 9.4 | 9.4 | 12.5 |
* Time-points are shown in Figure 1. T1, 3 weeks (early lactation); T2, 4 months and T3, 6 months (established lactation); T4, 12 months (after lactation).
Anthropometric values and α-diversity (Shannon and Chao 1 indexes) in women over one year after giving birth.
| All Women ( | UM-A ( | UM-B ( | |
|---|---|---|---|
| BMI (kg/m2) | |||
| T1 * | 25.8 ± 3.5 (19.5–33.3) a | 25.3 ± 2.9 (22.0–30.9) a | 26.3 ± 4.1 (19.5–33.3) a |
| T2 | 25.1 ± 3.8 (19.8–35.8) b | 24.5 ± 2.8 (20.8–29.2) ab | 25.7 ± 4.5 (19.8–35.8) a |
| T3 | 24.9 ± 4.0 (19.8–36.1) b | 24.3 ± 2.9 (20.5–29.5) b | 25.5 ± 4.8 (19.8–36.1) a |
| T4 | 24.3 ± 4.1 (18.7–35.8) c | 23.5 ± 3.3 (18.7–31.1) c | 25.0 ± 4.7 (18.7–35.8) b |
| <0.001 | 0.001 | 0.029 | |
| Waist (cm) | |||
| T1 | 92.6 ± 8.0 (76.5–109.0) a | 91.5 ± 6.2 (76.5–99.5) a | 93.6 ± 9.5 (78.7–109.0) a |
| T2 | 89.4 ± 8.3 (68.0–110.0) b | 89.0 ± 7.2 (78.0–101.0) ab | 89.8 ± 9.5 (68.0–110.0) b |
| T3 | 88.0 ± 9.4 (70.0–113.0) bc | 87.0 ± 9.0 (70.0–104.0) b | 89.1 ± 10.0 (76.0–113.0) b |
| T4 | 85.8 ± 10.4 (65.0–115.0) c | 83.0 ± 8.8 (65.0–97.5)c | 88.5 ± 11.3 (72.5–115.0) b |
| <0.001 | 0.001 | 0.021 | |
| Hip (cm) | |||
| T1 | 99.9 ± 8.1(86.0–116.0) a | 98.6 ± 6.7 (87.5–110.5) a | 101.2 ± 9.2 (86.0–116.0) a |
| T2 | 95.7 ± 8.7 (78.0–115.0) b | 94.6 ± 9.1 (80.0–109.0) ab | 96.8 ± 8.5 (78.0–115.0) ab |
| T3 | 95.7 ± 9.6 (81.0–123.0) b | 94.0 ± 8.7 (81.0–111.0) b | 97.3 ± 10.5 (83.0–123.0) ab |
| T4 | 94.7 ± 11.1 (78.0–125.0) b | 93.1 ± 10.3 (78.0–111.5) b | 96.5 ± 12.2 (79.0–125.0) b |
| 0.010 | 0.060 | 0.107 | |
| Waist/Hip | |||
| T1 | 0.93 ± 0.05 (0.75–1.02) ab | 0.93 ± 0.05 (0.85–1.02) a | 0.93 ± 0.05 (0.75–0.99) a |
| T2 | 0.93 ± 0.05 (0.83–1.03) a | 0.94 ± 0.05 (0.83–1.03) a | 0.93 ± 0.04 (0.83–0.99) a |
| T3 | 0.92 ± 0.04 (0.81–1.00) b | 0.93 ± 0.05 (0.84–1.00) a | 0.92 ± 0.04 (0.81–1.00) a |
| T4 | 0.91 ± 0.06 (0.72–0.99) b | 0.89 ± 0.07 (0.72–0.98) b | 0.93 ± 0.04 (0.87–0.99) a |
| 0.025 | 0.026 | 0.203 | |
| Shannon | |||
| T1 | 4.4 ± 0.9 a | 4.3 ± 0.1 a | 4.5 ± 0.1 a |
| T2 | 4.4 ± 0.7 a | 4.3 ± 0.1 a | 4.4 ± 0.1 a |
| T3 | 4.3 ± 0.1 a | 4.2 ± 0.1 a | 4.3 ± 0.2 a |
| T4 | 4.3 ± 0.1 a | 4.2 ± 0.1 a | 4.5 ± 0.1 a |
| 0.607 | 0.749 | 0.659 | |
| Chao 1 | |||
| T1 | 2472.2 ± 132.2 a | 2299.6 ± 152.6 a | 2644.8 ± 215.9 a |
| T2 | 2204.5 ± 151.9 a | 2129.1 ± 175.5 a | 2279.8 ± 248.2 ab |
| T3 | 1785.2 ± 154.2 b | 1652.7 ± 178.1 b | 1917.7 ± 251.9 b |
| T4 | 1848.4 ± 110.8 b | 1685.3 ± 127.9 b | 2011.5 ± 181.0 b |
| 0.004 | 0.011 | 0.078 | |
* Time-points are shown in Figure 1. T1, 3 weeks (early lactation); T2, 4 months and T3, 6 months (established lactation); T4, 12 months (after lactation). Values are expressed as mean ± standard deviation (SD) and range in brackets. Values with different letters within each column are significantly different using the Bonferroni test (p < 0.05). ⱡ Pillai’s trace for ANCOVA analysis.
Figure 2Microbial taxonomic composition in fecal samples of mothers through postpartum. (A) The bars show the mean proportion at the phylum level. T1: early lactation stage (3 weeks after delivery); T2 and T3: established lactation stage (4 and 6 months after delivery, respectively); T4: after lactation stage (12 months after delivery); Control (CT): healthy adult cohort (n = 249) previously published [18]. (B) Principal component analysis (PCA) and clustering analysis that shows differences in fecal microbiome through postpartum. (C) Box plots of second axes of the PCA (PC2) through postpartum in UM-A and UM-B groups.
Figure 3Linear discriminant analysis (LDA) effect size (LEfSe) analysis of gut microbiota that shows different abundances through postpartum in (A) maternal fecal microbiome and (B) inferred functional capacity of the fecal microbiome. Positive LDA scores (green bars) are enriched after the lactation stage (T4, 12 months after delivery) while negative LDA scores (red bars) are enriched in the early lactation stage (T1, 3 weeks after delivery). The microbial taxa and functions shown in the Figure have a LDA score higher than 2.
Figure 4Linear discriminant analysis (LDA) effect size (LEfSe) analysis of gut microbiota that shows different abundances between urolithin metabotypes (Ums) in the maternal fecal microbiome (A,B), and the inferred functional capacity of the fecal microbiome (C,D) at T1 (A,C) and T4 (B,D). Positive LDA scores (green bars) are enriched in UM-B while negative LDA scores (red bars) are enriched in UM-A. The microbial taxa and functions shown in the figure have a LDA score higher than 2.
Figure 5Spearman’s correlations heatmap between specific microbial groups and microbiota functions through postpartum. *: Spearman’s correlation values at p < 0.05 and #: 0.05 > p > 0.1. Microbial groups and functions augmented in UM-B (red color) and UM-A (blue color) were included. The strongest positive (r = 1) and negative correlations (r = −1) are indicated in red and blue, respectively.
Figure 6Spearman’s correlations heatmap (A) and principal component analysis (B) of changes through postpartum in microbial and anthropometric values. Changes in microorganisms and anthropometric values through postpartum were obtained by subtracting the initial values (T1, early lactation stage) from the finals (T4, after lactation stage) *: Spearman’s correlation values at p < 0.05 and #: 0.05 > p > 0.1. The strongest positive (r = 1) and negative correlations (r = −1) are indicated in red and blue, respectively. The microbial groups increased in UM-B (red color) and UM-A (blue color) were included in the PCA plot.